Abstract

Introduction: BK virus is an opportunistic infectious disease that causes disease and serious problems when the immune system is suppressed. One of the treatments used against this virus is intravenous immunoglobulin (IVIG). We aimed to review the major relevant articles in case of the efficacy of IVIG and determine its usefulness. Methods: We searched online databases such as PubMed, MEDLINE, Wiley, EMBASE, ProQuest Dissertations and Thesis, ISI Web of Knowledge, Scopus, and Google scholar. Two reviewers have independently assessed and extracted the titles and abstracts. Disagreements were being fixed by discussion. Where resolve was not feasible, a third review author was discussed. Results: We screened a total of 6 full texts. Three studies evaluated the effectiveness of IVIG in the Treatment of BK Infection in Renal Transplant Patients. Also, three studies assessed the various treatment options for Nephropathy due to the BK virus. Results showed that mean peak BK reduced with IVIG therapy after a one-year follow-up. Also, a high percentage of patients have functioning grafts after IVIG therapy. Conclusion: A review of studies shown powerful follow-up and early decrease of immunosuppression leading detection of BK viremia, with qualitative monitoring, can avoid the progress of clinically notable BK nephropathy. Combination treatment IVIG is more successful in removing viral load in patients with BKVAN, compared with traditional standard-of-care therapy.